相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intestinal Absorption Mechanism of Mirabegron, a Potent and Selective β3-Adrenoceptor Agonist: Involvement of Human Efflux and/or Influx Transport Systems
Shin Takusagawa et al.
MOLECULAR PHARMACEUTICS (2013)
Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor Agonist: Results From Two Phase I, Randomized, Multiple-Dose Studies in Healthy Young and Elderly Men and Women
Walter Krauwinkel et al.
CLINICAL THERAPEUTICS (2012)
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder
Charlotte Eltink et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Development and validation of LC-MS/MS methods for the determination of mirabegron and its metabolites in human plasma and their application to a clinical pharmacokinetic study
Raymond van Teijlingen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Identification of human cytochrome P450 isoforms and esterases involved in the metabolism of mirabegron, a potent and selective β3-adrenoceptor agonist
Shin Takusagawa et al.
XENOBIOTICA (2012)
Absorption, Metabolism and Excretion of [14C]Mirabegron (YM178), a Potent and Selective β3-Adrenoceptor Agonist, after Oral Administration to Healthy Male Volunteers
Shin Takusagawa et al.
DRUG METABOLISM AND DISPOSITION (2012)
Effect of (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective β3-adrenoceptor agonist, on bladder function
Toshiyuki Takasu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The development of the oral controlled absorption system (OCAS®):: A new improved formulation of tamsulosin
CR Chapple
EUROPEAN UROLOGY SUPPLEMENTS (2005)
Confidence interval criteria for assessment of dose proportionality
BP Smith et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
